Agenda
3:30 PM - 4:30 PM (EST) | Opening Keynote
Join the Florida Department of Health for an in-depth discussion on how their data exchange capacity for disease surveillance has evolved and progressed in 2020 and what new initiatives are in the works for 2021. Allison Culpepper’s team works to promote the health of all Floridians from infectious diseases through disease surveillance. This involves the collection and analysis of population-level health data; investigation of acute outbreaks; and education and consultation to county, local, and private health agencies on infectious diseases. Allison’s presentation will be followed by a fireside chat discussion with Mark Hagland, editor-in-chief, of Healthcare Innovation and Pamela King the state of Florida’s HIE coordinator. Grab your favorite zoom shirt, a tasty beverage, and join us for this fantastic opening session
Allison Culpepper, Data Acquisition Unit Manager, Florida Department of Health Eduardo Gonzalez Loumiet, CEO, Ruvos David Atrubin, Surveillance Epidemiologist, Florida Department of Health Pam King, Outreach Coordinator, AHCA Mark Hagland, Editor-in-Chief, Healthcare Innovation Session created in partnership with: |
9:30 AM - 10:30 AM (EST) | Tailboard Talk
Throughout healthcare systems nationwide, leadership roles and responsibilities keep evolving just as the industry landscape continues to shift. One example of this is how the chief medical information officer (CMIO) role has grown over time, from a liaison between the clinical and technical staff to one that has become less technical and more operational. Join us for a discussion on the skills that CMIOs need to be successful, ensure they have a seat at the executive leadership team table, and can grow/evolve their skills over time to meet the demands of a rapidly changing healthcare environment.
John McGreevey, Associate Chief Medical Information Officer and Assistant Professor of Clinical Medicine, Penn Medicine, University of Pennsylvania Health System Angela Tiberio, Physician Executive/Clinical Solutions Leader, Impact Advisors Mark Hagland, Editor-in-Chief, Healthcare Innovation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11:00 AM - 11:30 AM (EST) | Provider Spotlight
Join Susan Voltz for an in-depth discussion on Nemours' advancements in telehealth in response to COVID-19 and the operational transformation required to continue to support telehealth in 2021 and beyond.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12:30 PM - 1:00 PM (EST) | Industry Partner Spotlight
Join Ivanti for in-depth discussion on how IT and security leaders can continue to provide top-tier service to their internal customers and keep the enterprise secure during the time of rapidly changing business demands. This session will focus on delivering IT resources, the current cyber threat landscape in healthcare and provide tips for IT and security professionals to use within their own organizations.
Session supported by:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1:00 PM - 1:30 PM (EST) | Industry Partner Spotlight
Many healthcare organizations are stretched to their limits to meet the demands of a global pandemic while striving to offer the best possible outcomes for all their patients. Likewise, IT teams are challenged to enable clinicians and staff to perform at their best under highly stressful conditions. Endpoint user experiences, security, and continual access to key healthcare apps – within healthcare facilities or from home – cannot be compromised. In this session, IGEL will discuss how IGEL OS – the next-gen edge OS for cloud workspaces, can help healthcare workers perform at their utmost during the most trying times, from anywhere, while meeting patient data protection requirements. And at the same time enabling healthcare organizations to save money and react quicker to fast-changing conditions during these unusual times.
Simon Clephan, VP Business Development and Alliances, IGEL Dan O’Farrell, Sr. Director Product Marketing, IGEL
Session supported by:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2:00 PM - 3:00 PM (EST) | Tailboard Talk
EMR usability as well as the efficiencies of a well-built EMR are hugely important for physicians. Join our panelists to discuss how they build a culture of partnership between physician and clinician users, and IT personnel, to drive a quality EMR experience, increase EMR engagement, and helping users focus on opportunities for EMR success in their organizations. Discussion topics include:
Kendall Webb, Executive Medical Director of EHR Integration and Innovation, UF Health Jacksonville Roy Hammar, Chief of Client Engagement, DSS Inc. Tommy Rowley, Provider Success - Arch Collaborative, KLAS Research Mark Hagland, Editor-in-Chief, Healthcare Innovation
Session presented in partnership with: Session supported by: |
11:00 AM - 11:45 AM | Provider Spotlight
Leaders at the University of Minnesota Health and Fairview Health Services, together with researchers from Amgen, have collaborated to create a framework for better predicting the potential for severe infection among chemotherapy patients. Approximately 20% of advanced cancer patients receive treatment that weakens their immune systems and increases the risk of life-threatening infections, in particular, a form of infection known as febrile neutropenia. A good proportion of these complications can be prevented using FDA-approved medications. The problem? There has been no clear standard of care with regard to the prescribing of those medications, with countless patients remaining at undetermined levels of risk. Leaders from all three organizations created a multidisciplinary research team to investigate this issue, extracting data from over 50,000 patients to identify over 8,000 eligible patients at risk for febrile neutropenia and provide granular details into its rates of occurrence. They will share their data analytics journey during this session that is part presentation and part discussion.
Arpit Rao, Asst. Professor and Director, Oncology Quality & Safety, University of Minnesota Adam Rhodes, Information Technology Manager, Fairview Pharmacy Services, Fairview Health Services
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12:30 PM - 1:00 PM | Industry Partner Spotlight
The leaders of patient care organizations are facing multiple challenges around data these days. Among the challenges facing them have to do with the need to obtain clean, complete, and compliant data, and to be able to use it with agility. In this discussion, participants will be able to share their perspectives on the current strategic data challenges in their organizations, and how they’re strategizing forward.
Session supported by:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1:00 PM - 1:30 PM | Industry Partner Spotlight
Join Dan Cowan for a presentation on the implementation of hybrid cloud solutions in healthcare. This session will focus on application strategy, hyper-converged infrastructure, and virtualization strategies you can deploy in your organization.
Sessions supported by:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2:00 PM - 3:00 PM |
Opioids overdose deaths continue to increase in the United States and NCPDP has had a priority focus on developing a solution to help address the epidemic since 2013. Join Lee Ann Stember, NCPDP’s President & CEO, as she provides an overview of NCPDP's standards-based model for prescription drug monitoring programs (PDMPs) with best practice guidance to help providers to make informed decisions at the point of prescribing. The model solution is intended to provide access for patients with a valid medical need and reduce fraud and abuse. PDMPs, the state-operated databases that collect information on dispensed medications, have evolved historically since the program was first enacted in 1939 in California to enforce drug laws. Still, the overall effectiveness of PDMPs is challenged by a lack of standards to share drug abuse information within and across the states to address potential drug abuse and diversion. Stember will also share her personal connection with the issue, with a special guest and a call to action on how to engage and help make a difference.
|
Thank you to our Sponsors and Partners